1. Home
  2. ADMA vs DHC Comparison

ADMA vs DHC Comparison

Compare ADMA & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$8.44

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Diversified Healthcare Trust of Beneficial Interest

DHC

Diversified Healthcare Trust of Beneficial Interest

HOLD

Current Price

$8.92

Market Cap

2.2B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADMA
DHC
Founded
2004
1998
Country
United States
United States
Employees
647
585
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
ADMA
DHC
Price
$8.44
$8.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$25.67
$8.00
AVG Volume (30 Days)
2.6M
1.2M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
0.53%
EPS Growth
N/A
N/A
EPS
0.19
N/A
Revenue
$42,219,783.00
N/A
Revenue This Year
$27.46
$3.13
Revenue Next Year
$22.11
$7.00
P/E Ratio
$45.79
N/A
Revenue Growth
43.85
N/A
52 Week Low
$7.21
$3.24
52 Week High
$20.46
$9.66

Technical Indicators

Market Signals
Indicator
ADMA
DHC
Relative Strength Index (RSI) 43.53 46.85
Support Level $8.20 $8.67
Resistance Level $8.97 $9.14
Average True Range (ATR) 0.26 0.30
MACD -0.02 -0.05
Stochastic Oscillator 28.57 22.40

Price Performance

Historical Comparison
ADMA
DHC

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

About DHC Diversified Healthcare Trust of Beneficial Interest

Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. The company has two reportable segments: SHOP (Senior Housing Operating Portfolio) and Medical Office and Life Science Portfolio. The SHOP segment includes managed senior living communities providing residential living and care services. The Medical Office and Life Science Portfolio segment consists of properties leased to medical providers and biotechnology laboratories. It generates the majority of its revenue from the SHOP segment.

Share on Social Networks: